1. Home
  2. West Africa
  3. Mali

Government signs up for cheaper AIDS drugs

The Malian government has signed an agreement with four international pharmaceutical companies to drastically reduce the cost of drugs which suppress the growth of HIV, AFP reported. A treatment which used to cost some US $480 per patient each month will now cost between $60 and $110 monthly, Malian Health Minister Traore Fatoumata Nafo told reporters on Saturday. The companies that signed the deal are Boehringer-Ingelheim from Germany, GlaxoSmithKline from Britain and US firms, Merck and Bristol Myers Squibb. The South African government is currently engaged in a court battle with 39 pharmaceutical companies to facilitate access to cheaper medicine.

This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Get the day’s top headlines in your inbox every morning

Starting at just $5 a month, you can become a member of The New Humanitarian and receive our premium newsletter, DAWNS Digest.

DAWNS Digest has been the trusted essential morning read for global aid and foreign policy professionals for more than 10 years.

Government, media, global governance organisations, NGOs, academics, and more subscribe to DAWNS to receive the day’s top global headlines of news and analysis in their inboxes every weekday morning.

It’s the perfect way to start your day.

Become a member of The New Humanitarian today and you’ll automatically be subscribed to DAWNS Digest – free of charge.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join